Int J Radiat Oncol Biol Phys
ChemoradiotherapyDiet TherapyEsophagitis
Dr. Thomas J. Gergel, MD
NPI1255309944PAC ID9335115393
- Medicare services, 2024
- 1,445
- Medicare patients, 2024
- 244
- Part D claims, 2024
- 426
- Publications
- 2
- Clinical trials
- 10
- Practice address
- One Guthrie Square, Sayre, PA 18840
- Practice phone
- Call (570) 888-6666
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Gergel's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Thomas J. Gergel is a radiation oncologist in Sayre, Pennsylvania
Dr. Gergel practices at Guthrie Robert Packer Hospital in Sayre, Pennsylvania, part of The Guthrie Clinic.
Dr. Gergel's NPI, 1255309944, was assigned on March 9, 2006. Dr. Gergel graduated from State University of New York at Buffalo School of Medicine in 1998. Dr. Gergel holds Pennsylvania license MD421616.
NPI and contact details
- NPI
- 1255309944NPI Registry (opens in a new tab)
- Medicare PAC ID
- 9335115393
- NPI enumeration date
- March 9, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (570) 888-6666
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 54
- Medical school graduation
- 1998
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Thomas J. Gergel practices at 2 locations in Sayre, Pennsylvania
Dr. Gergel's primary practice is Guthrie Robert Packer Hospital, at One Guthrie Square, Sayre, PA 18840 in Bradford County. The practice phone is (570) 888-6666. Dr. Gergel also practices at Guthrie Robert Packer Hospital, 1 Guthrie Sq, Sayre, PA 18840.
- Guthrie Robert Packer HospitalPrimaryOne Guthrie Square, Sayre, PA 18840 · Bradford CountyPhone(570) 888-6666
- Guthrie Robert Packer Hospital1 Guthrie Sq, Sayre, PA 18840 · Bradford CountyPhone(570) 888-6666
Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data
Dr. Thomas J. Gergel is affiliated with 5 sites of care and 1 medical group
Dr. Gergel's primary practice is Guthrie Robert Packer Hospital in Sayre, Pennsylvania, part of The Guthrie Clinic. Dr. Gergel is also affiliated with Guthrie Lourdes Hospital. The medical group on file is Guthrie Medical Group. Dmand AI also links Dr. Gergel to 2 more hospitals and 1 breast imaging center, each named with a free account.
Guthrie Lourdes HospitalGuthrie Medical Group2 hospitalsNames with a free account1 breast imaging centerName with a free account
See all 6 affiliations for Dr. GergelSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Thomas J. Gergel's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gergel practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Guthrie Robert Packer Hospital | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Gergel practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across The Guthrie Clinic and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Thomas J. Gergel is one of 304 radiation oncologists in Pennsylvania
Radiation oncology is Dr. Gergel's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Gergel is licensed in Pennsylvania.
Specialties and state licenses
- Radiation oncology, PennsylvaniaPrimary
Radiation oncologists near Dr. Gergel
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
304radiation oncologists in Pennsylvania
2radiation oncologists in Sayre
2radiation oncologists at Guthrie Robert Packer HospitalSources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Thomas J. Gergel billed Medicare for 1,445 services in 2024
CMS data shows 1,445 Medicare services from Dr. Gergel across 20 procedure codes in 2024, for 244 Medicare patients. Medicare paid $106,214 for them.
Medicare services, 20241,445
Medicare patients244
Paid by Medicare$106,214
Procedure codes20
Dr. Gergel's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Imaging
- 2023: 1,0332024: 1,1198%
- Office and hospital visits
- 2023: 1922024: 24628%
- Surgery
- 2023: 362024: 80122%
Where Dr. Gergel's Medicare services took place, 2024
- In an office433%
- In a facility1,40297%
Dr. Gergel compared with the Pennsylvania median for radiation oncologists, 2024
- Dr. Gergel
- Pennsylvania median
- Medicare services
- 1,445vs 1,02741% above
- Medicare patients
- 244vs 16052% above
- Part D claims
- 310vs 397.9 times
Medians across 308 radiation oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Gergel's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Gergel?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Gergel and other radiation oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Thomas J. Gergel treated 244 Medicare patients in 2024, average age 75
CMS counts 244 Medicare patients who saw Dr. Gergel in 2024. The largest group is 75 to 84, with 105 patients. 75% of them have cancer, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Gergel's median patient age at 74, with 34% women.
Medicare patients, 2024244
Average age75
Average risk score1.59
Also on Medicaid10%
Dr. Gergel's Medicare patients by age, 2024
Dr. Gergel's Medicare patients by sex, 2024
- Women8836%
- Men15664%
Chronic conditions among Dr. Gergel's Medicare patients, 2024
- Cancer75%
- High cholesterol75%
- High blood pressure72%
- Ischemic heart disease34%
- Arthritis33%
- Diabetes33%
- COPD28%
- Atrial fibrillation24%
Share of Medicare patients with each condition. A patient can have several.
Dr. Gergel's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women34%
- Men65%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Thomas J. Gergel wrote 426 Medicare Part D claims in 2024
In 2024, Dr. Gergel wrote 426 Medicare Part D claims for 159 patients. 92% of them were for generic drugs. CMS names the drug for 310 of them, across 11 drugs with 11 or more claims each, at $5,478 in total drug cost. In 2023, CMS named 179 claims across 8 drugs.
Part D claims, 2024426
Drugs named by CMS11
Total drug cost$5,478
Part D patients159
Dr. Gergel's Part D claims by kind of drug, 2024
- Generic394 claims92%
- Brand-name32 claims8%
Dr. Gergel's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Gergel's Part D claims, 2024
- Opioids13%55 of 426 claims
- Antibiotics12%53 of 426 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1792024: 31073%
Drugs named by CMS: 11 in 2024, 8 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Thomas J. Gergel takes part in Medicare
Dr. Gergel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find radiation oncologists like Dr. Gergel by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Thomas J. Gergel has 2 publications on record
Dmand AI links 2 papers to Dr. Gergel in 2016. 2016 was the busiest year, with 2. Dr. Gergel's most frequent co-authors are Lawrence Bruce Berk, MD, Albert S. Denittis, MD and Shannon Elizabeth Fogh, MD.
Papers2
Dr. Gergel's most frequent co-authors
- Lawrence Bruce Berk, MD2 shared papers
- Albert S. Denittis, MD2 shared papers
- Shannon Elizabeth Fogh, MD2 shared papers
Recent publications by Dr. Gergel
See who Dr. Gergel researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Gergel works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Thomas J. Gergel has worked on 10 clinical trials
Dmand AI links Dr. Gergel to 10 clinical trials, 6 of them phase 3 studies. 10 are still active or recruiting. Conditions studied include Breast Neoplasms, Brain Neoplasms and Carcinoma, Lobular. NRG Oncology sponsors the most, 4.
Clinical trials with Dr. Gergel by phase
- NonePhase 1: no trials
- 3Phase 2: 3 trials
- 1Phase 2/3: 1 trial
- 6Phase 3: 6 trials
- NonePhase 4: no trials
Conditions in Dr. Gergel's trials
- Breast Neoplasms
- Brain Neoplasms
- Carcinoma, Lobular
- Carcinoma, Non-Small-Cell Lung
- Inflammatory Breast Neoplasms
Investigators on the most trials with Dr. Gergel
- Mitchel L. Fromm, MD6 shared trials
- Richard S. Hudes, MD5 shared trials
- Daniel H. Barnett, MD4 shared trials
Recent clinical trials with Dr. Gergel
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently With Radiotherapy Versus Radiotherapy Alone for Inflammatory Breast Cancer (opens in a new tab)
Active, not recruitingPhase 2
Inflammatory Breast NeoplasmsBreast NeoplasmsOlaparibRadiation Therapy
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial (opens in a new tab)
Active, not recruitingPhase 2
Carcinoma, Non-Small-Cell LungCarcinoma, BronchogenicDocetaxelErlotinib HydrochlorideGemcitabine
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer (opens in a new tab)
Active, not recruitingPhase 2/3
Lymphatic MetastasisNeoplasm MetastasisStereotactic Body Radiotherapy
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS for Resected Metastatic Brain Disease (opens in a new tab)
Active, not recruitingPhase 3
Brain NeoplasmsCentral Nervous System NeoplasmsSingle Fraction Stereotactic RadiosurgeryFractionated Stereotactic Radiosurgery
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) (opens in a new tab)
Active, not recruitingPhase 3
Lung NeoplasmsThoracic NeoplasmsAtezolizumabCarboplatinCisplatin
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Thomas J. Gergel received $474 in industry payments from 2017 to 2025
CMS Open Payments shows 15 general payments to Dr. Gergel from 7 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Siemens Medical Solutions USA, Inc. paid the most, $194.
General payments to Dr. Gergel by program year, 2017 to 2025
Companies that paid Dr. Gergel the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Thomas J. Gergel graduated from State University of New York at Buffalo School of Medicine
Dr. Gergel graduated from State University of New York at Buffalo School of Medicine in 1998.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Thomas J. Gergel's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Thomas J. Gergel
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Thomas J. Gergel's NPI number?
Dr. Thomas J. Gergel's NPI number is 1255309944. It was assigned on March 9, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Thomas J. Gergel?
Dr. Thomas J. Gergel is a radiation oncologist in Sayre, Pennsylvania. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Thomas J. Gergel practice?
Dr. Gergel practices at One Guthrie Square, Sayre, PA 18840. Dr. Gergel also practices at 1 Guthrie Sq, Sayre, PA 18840. Dr. Gergel's primary practice is Guthrie Robert Packer Hospital in Sayre, Pennsylvania, part of The Guthrie Clinic. Dmand AI also links Dr. Gergel to 2 hospitals and 1 breast imaging center.
What is Dr. Thomas J. Gergel's office phone number?
The practice phone on file for Dr. Gergel is (570) 888-6666.
What is Dr. Thomas J. Gergel's medical license number?
Dr. Gergel holds Pennsylvania license MD421616.
Which hospitals is Dr. Thomas J. Gergel affiliated with?
Dr. Gergel practices at Guthrie Robert Packer Hospital in Sayre, Pennsylvania. Dr. Gergel is also affiliated with Guthrie Lourdes Hospital. Dmand AI links Dr. Gergel to 2 more hospitals.
What medical group is Dr. Thomas J. Gergel part of?
Dr. Gergel is linked to Guthrie Medical Group.
Does Dr. Thomas J. Gergel accept Medicare?
Yes. CMS data shows Dr. Gergel billed Medicare for 1,445 services in 2024, and Dr. Gergel accepts Medicare assignment.
How many Medicare patients does Dr. Thomas J. Gergel see?
CMS counts 244 Medicare patients who saw Dr. Gergel in 2024, with an average age of 75.
What services does Dr. Thomas J. Gergel bill to Medicare?
In 2024, Dr. Gergel's most billed Medicare services were radiation oncology (77014), radiation oncology (77300) and radiation oncology (77427).
Show 6 more questionsShow fewer questions
Where did Dr. Thomas J. Gergel go to medical school?
Dr. Gergel graduated from State University of New York at Buffalo School of Medicine in 1998.
What drugs does Dr. Thomas J. Gergel prescribe most?
In 2024 Medicare Part D data, Dr. Gergel's most prescribed drugs by claims were Tamsulosin HCl, Ciprofloxacin HCl and Oxycodone HCl.
Has Dr. Thomas J. Gergel received payments from drug or device companies?
CMS Open Payments shows $474 in general payments to Dr. Gergel from 7 companies from 2017 to 2025. The largest total came from Siemens Medical Solutions USA, Inc.
How long has Dr. Thomas J. Gergel been practicing?
Dr. Gergel graduated from medical school in 1998, 28 years ago.
Does Dr. Thomas J. Gergel do research?
Dmand AI links 2 publications to Dr. Gergel. Dr. Gergel has worked on 10 clinical trials.
Who does Dr. Thomas J. Gergel publish with?
Dr. Gergel's most frequent co-authors are Lawrence Bruce Berk, MD (2 shared papers), Albert S. Denittis, MD (2 shared papers) and Shannon Elizabeth Fogh, MD (2 shared papers).
Selling to radiation oncology practices?
See radiation oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card